Avandia – A Risk Worth Taking?
September 6, 2010
The panorama broadcast of 6/Sept/10 reported how the Heart attack side effects of the drug Avandia , far outweigh its benefits to diabetes sufferers.
The program also reported how GlaxoSmithKline controlled and manipulated the “clinical trials” to get “better results”.
It also reported the closed practises of the BMA-British Medical Association ( a kind of doctors trade union) who operate in the interests of the drug companies and not the patients.
I have worked in elderly care homes and seen the vast number of unnecessary drugs given to elderly and sectioned residents.
In the interests of saving lives and not wasting money there are some measures the government can take.
1. As done in the USA, all pharmaceutical companies must publish how much they have paid to each UK doctor for selling their drugs.
2. There needs to be a independent British or EU organization which can heavily fine these drug companies.
